67Cu-SAR-BBN

N/A

Report date: 2025/11/20 11:38:12
NME

Base Information

Drug Name67Cu-SAR-BBN
Drug Alias NameCopper 67-labeled MeCOSar-PEG4-Bombesin(Clarity Pharmaceuticals)67Cu-SAR-Bombesin
ClassificationRadiation-emitting products > Nuclides > Copper > 67CuRadiation-emitting products > Radionuclide Drug ConjugatesSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[4] 
Mechanisms of ActionGastrin releasing peptide receptor antagonists
TargetsGastrin releasing peptide receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesClarity Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClarity Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A